Abstract
Willingness to receive the newly developed Coronavirus Disease-2019 (COVID-19) vaccines is highly variable. To assess the receptiveness of a select sample of North Carolinians to COVID-19 vaccination, a brief survey was conducted among participants in the COVID-19 Community Research Partnership (CCRP) affiliated with five medical centers in North Carolina. A total of 20,232 CCRP participants completed a multiple choice, mini survey electronically between December 17, 2020 and January 13, 2021. Of the 20,232 survey respondents, 15,422 (76.2%) were receptive to vaccination. Vaccine receptiveness increased incrementally with age with those >70 years being the most willing to be vaccinated compared to all other age groups. Respondents with no previous COVID-19 diagnosis were more likely to accept the vaccine compared to those that have a previous COVID-19 diagnosis (76.6% vs 60.9%). Comparative analysis of gender, race/ethnicity, and residence locale revealed that women, African Americans, and suburban participants were less willing to get a COVID-19 vaccine. There was no difference in vaccine intent based on healthcare worker status. Of those unwilling to get the vaccine, 82% indicated that the reason was uncertainty about the safety and efficacy of the vaccine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: This work was supported by the Coronavirus Aid, Relief, and Economic Security (CARES) Act by the U.S. Department of the Treasury.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board Statement: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Wake Forest School of Medicine Institutional Review Board, protocol [IRB00064912].
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
NA
Abbreviations
- BIPOC
- Blacks, Indigenous and People of color
- CCRP
- COVID-19 Community Research Partnership
- CDC
- Centers for Disease Control and Prevention
- COVID-19
- Coronavirus disease 2019
- CoVPN
- COVID-19 Prevention Network
- EUA
- Emergency Use Authorization
- FDA
- Food and Drug Administration
- KFF
- Kaiser Family Foundation
- NC
- North Carolina
- NIAID
- National Institute of Allergy and Infectious Diseases
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus-2
- US
- United States
- WHO
- World Health Organization
